Norvegija - norvegų - Statens legemiddelverk

abacus medicine a/s - venetoklaks - tablett, filmdrasjert - 100 mg

Europos Sąjunga - norvegų - EMA (European Medicines Agency)

stemline therapeutics b.v. - elacestrant - bryst neoplasms - endokrin terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Norvegija - norvegų - Statens legemiddelverk

cis bio international - natriumjodid (131 i) - kapsel, hard - 50 mbq

Norvegija - norvegų - Statens legemiddelverk

ge healthcare b.v. - natriummolybdat mo-99 omdannes til natriumperteknetat tc-99m - radionuklidegenerator

Norvegija - norvegų - Statens legemiddelverk

curium netherlands b.v. - natriumjodid (131i) - kapsel, hard

Norvegija - norvegų - Statens legemiddelverk

ge healthcare buchler gmbh & co. kg - natriumjodid (131i) - kapsel, hard

Norvegija - norvegų - Statens legemiddelverk

orifarm as - vismodegib - kapsel, hard - 150 mg

Norvegija - norvegų - Statens legemiddelverk

2care4 aps - vismodegib - kapsel, hard - 150 mg

Europos Sąjunga - norvegų - EMA (European Medicines Agency)

astrazeneca ab - moxetumomab pasudotox - leukemi, hårete celler - antineoplastiske midler - lumoxiti as monotherapy is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukaemia (hcl) after receiving at least two prior systemic therapies, including treatment with a purine nucleoside analogue (pna).

Norvegija - norvegų - Statens legemiddelverk

abacus medicine a/s - vismodegib - kapsel, hard - 150 mg